ES2230433T3 - Procedimientos para la preparacion de derivados de indolopirrolocarbazol. - Google Patents

Procedimientos para la preparacion de derivados de indolopirrolocarbazol.

Info

Publication number
ES2230433T3
ES2230433T3 ES02018235T ES02018235T ES2230433T3 ES 2230433 T3 ES2230433 T3 ES 2230433T3 ES 02018235 T ES02018235 T ES 02018235T ES 02018235 T ES02018235 T ES 02018235T ES 2230433 T3 ES2230433 T3 ES 2230433T3
Authority
ES
Spain
Prior art keywords
compound
formula
group
baselineskip
same meanings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02018235T
Other languages
English (en)
Spanish (es)
Inventor
Katsuhisa C/O Banyu Pharmaceutical Co Ltd Kojiri
Hisao C/O Banyu Pharmaceutical Co Ltd Kondo
Hiroharu Banyu Pharma Co. Ltd Arakawa
Mitsuru Banyu Pharmaceutical Co Ltd Ohkubo
Hiroyuki Banyu Pharmaceutical Co Ltd Suda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Application granted granted Critical
Publication of ES2230433T3 publication Critical patent/ES2230433T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/16—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
ES02018235T 1994-05-09 1995-05-02 Procedimientos para la preparacion de derivados de indolopirrolocarbazol. Expired - Lifetime ES2230433T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11948394 1994-05-09
JP11948394 1994-05-09
JP14564894 1994-06-03
JP14564894 1994-06-03

Publications (1)

Publication Number Publication Date
ES2230433T3 true ES2230433T3 (es) 2005-05-01

Family

ID=26457215

Family Applications (2)

Application Number Title Priority Date Filing Date
ES02018235T Expired - Lifetime ES2230433T3 (es) 1994-05-09 1995-05-02 Procedimientos para la preparacion de derivados de indolopirrolocarbazol.
ES95917506T Expired - Lifetime ES2206501T3 (es) 1994-05-09 1995-05-02 Derivado de indolopirrolocarbazol antitumoral.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95917506T Expired - Lifetime ES2206501T3 (es) 1994-05-09 1995-05-02 Derivado de indolopirrolocarbazol antitumoral.

Country Status (14)

Country Link
EP (2) EP0760375B1 (enExample)
JP (1) JP3038921B2 (enExample)
KR (1) KR100312473B1 (enExample)
CN (2) CN1285605C (enExample)
AT (2) ATE283863T1 (enExample)
AU (1) AU683749B2 (enExample)
CA (1) CA2190007C (enExample)
CL (1) CL2004001117A1 (enExample)
DE (2) DE69533833T2 (enExample)
DK (2) DK1264836T3 (enExample)
ES (2) ES2230433T3 (enExample)
HK (1) HK1000890A1 (enExample)
PT (2) PT760375E (enExample)
TW (1) TW313566B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050058444A (ko) * 2002-08-23 2005-06-16 반유 세이야꾸 가부시끼가이샤 인돌로피롤로카르바졸 유도체의 제조법
CN101585861B (zh) * 2009-07-03 2012-10-24 复旦大学 N-糖基萘并咔唑化合物及其合成方法和应用
WO2025082431A1 (zh) * 2023-10-18 2025-04-24 正大天晴药业集团股份有限公司 一种吲哚衍生物治疗头颈部肿瘤的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
EP0528030B1 (en) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
JP3707075B2 (ja) * 1994-06-13 2005-10-19 萬有製薬株式会社 グリコシルトランスフェラーゼをコードする遺伝子及びその用途
AU3086495A (en) * 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles

Also Published As

Publication number Publication date
ES2206501T3 (es) 2004-05-16
CL2004001117A1 (es) 2005-04-22
AU683749B2 (en) 1997-11-20
DK0760375T3 (da) 2003-12-29
DE69532198T2 (de) 2004-08-26
JP3038921B2 (ja) 2000-05-08
ATE255121T1 (de) 2003-12-15
DE69533833T2 (de) 2005-12-15
KR970702869A (ko) 1997-06-10
EP0760375A4 (en) 2002-03-27
HK1000890A1 (en) 2004-01-09
PT760375E (pt) 2004-04-30
EP1264836B1 (en) 2004-12-01
CN1106400C (zh) 2003-04-23
CN1285605C (zh) 2006-11-22
TW313566B (enExample) 1997-08-21
PT1264836E (pt) 2005-02-28
DE69532198D1 (de) 2004-01-08
EP1264836A1 (en) 2002-12-11
DE69533833D1 (de) 2005-01-05
CN1153518A (zh) 1997-07-02
DK1264836T3 (da) 2005-03-07
CN1513865A (zh) 2004-07-21
CA2190007A1 (en) 1995-11-16
EP0760375B1 (en) 2003-11-26
CA2190007C (en) 2003-04-15
AU2353595A (en) 1995-11-29
KR100312473B1 (ko) 2002-06-24
HK1067948A1 (en) 2005-04-22
EP0760375A1 (en) 1997-03-05
ATE283863T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
HU211556A9 (en) Pyrroloindole derivatives related to dc-88a compound
EP0354583B1 (en) DC-88A derivatives
US5187186A (en) Pyrroloindole derivatives
JPH05400B2 (enExample)
WO2014094354A1 (en) Preparation of maytansinoid esters
US6555677B2 (en) Phase transfer catalyzed glycosidation of an indolocarbazole
US5922860A (en) Antitumor indolopyrrolocarbazole derivatives
EP0580812A1 (en) Anti-tumor and anti-psoriatic agents
US5804564A (en) Antitumor indolopyrrolocarbazole derivatives
WO1995030682A1 (en) Antitumor indolopyprolocarbazole derivative
JPH05247055A (ja) スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤
WO1996004293A1 (en) Antitumor indolopyrrolocarbazoles
EP1264836B1 (en) Processes for the preparation of indolopyrrolocarbazole derivatives
US5008271A (en) DC-88A derivatives
JP4047383B2 (ja) 抗ウイルス活性を有するセスキテルペン誘導体
WO2021176473A1 (en) A process for the preparation of upadacitinib and its intermediates
US5876984A (en) Sequiterpene derivatives having antiviral activity
JPWO1997011947A1 (ja) 抗ウイルス活性を有するセスキテルペン誘導体
Okada et al. Amino acids and peptides. XLVII. Facile synthesis of flavacol, deoxymuta-aspergillic acid and optically active deoxyaspergillic Acid from dipeptidyl aldehydes
JPWO1995030682A1 (ja) 抗腫瘍性インドロピロロカルバゾール誘導体
EP1471068A1 (en) Process for total synthesis of ecteinascidins and intermediates therefor
CA2413037C (en) Intermediates for producing antitumor indolopyrrolocarbazole derivatives
AU646163C (en) Anti-tumor and anti-psoriatic agents
FI80047C (fi) Foerfarande foer framstaellning av rebeccamycinderivat.
Lessen Synthetic approaches to the total syntheses of naphthyridinomycin and quinocarcin: Preparation of advanced bicyclic lactam intermediates via intramolecular N-acyliminium ion cyclization